C Contini Selected Research

C Contini Research Topics

3	Nervous System Diseases (Neurological Disorders) 05/2008 - 02/2001
3	Acquired Immunodeficiency Syndrome (AIDS) 02/2002 - 02/2001
2	Toxoplasmosis 06/2008 - 01/2001
1	Neoplasms (Cancer) 12/2021
1	Colorectal Neoplasms (Colorectal Cancer) 12/2021
1	Hidradenitis Suppurativa 05/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Pre-Eclampsia (Preeclampsia) 04/2018
1	Ophthalmia Neonatorum 01/2018
1	Trachoma 01/2018
1	Eye Diseases (Eye Disease) 01/2018
1	Pneumonia (Pneumonitis) 03/2013
1	Opportunistic Infections (Opportunistic Infection) 06/2008
1	HIV Infections (HIV Infection) 06/2008
1	Multiple Sclerosis 05/2008
1	Relapsing-Remitting Multiple Sclerosis 08/2004
1	Encephalitis (Encephalitis, Rasmussen) 02/2002
1	Latent Infection 02/2002
1	Progressive Multifocal Leukoencephalopathy 02/2001
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2001

3	DNA (Deoxyribonucleic Acid)IBA 05/2008 - 02/2001
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2001
1	ThymosinIBA 12/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	CelluloseIBA 04/2018
1	Heparin (Liquaemin)FDA LinkGeneric 04/2018
1	Dextran SulfateIBA 04/2018
1	oxidized low density lipoproteinIBA 04/2018
1	Tyrosine (L-Tyrosine)FDA Link 04/2018
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2002
1	HIV AntigensIBA 10/2001
1	Immunoglobulin G (IgG)IBA 10/2001
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2001
1	SteroidsIBA 01/2001

1	Blood Component Removal (Apheresis) 04/2018
1	Therapeutics 01/2018
1	Intravesical Administration 03/2013
1	Highly Active Antiretroviral Therapy (HAART) 06/2008